Related Experiment Video
Updated: Sep 15, 2025

06:19
Constructing and Visualizing Models using Mime-based Machine-learning Framework
Published on: July 22, 2025
726
Clinical Stage Prompt Induced Multi-Modal Prognosis
IEEE Transactions on Medical Imaging
|July 14, 2025
Summary
This study introduces a novel framework, CiMP, for cancer survival prediction by integrating histology images and genomic data. CiMP utilizes clinical staging prompts to enhance multi-modal fusion, achieving state-of-the-art results.
Area of Science:
- Oncology
- Bioinformatics
- Medical Imaging
Background:
- Histology and genomic data are crucial for cancer prognosis.
- Integrating these modalities presents challenges in modeling high-order relevance and incorporating clinical knowledge.
- Existing methods often lack effective multi-modal fusion strategies for prognosis.
Purpose of the Study:
- To develop a novel framework for multi-modal cancer prognosis by integrating Whole Slide Images (WSIs) and genomic data.
- To address the challenges of high-dimensional data imbalance and the under-utilization of clinical knowledge in cancer survival prediction.
- To propose a prognosis-oriented image-omics fusion method that leverages clinical staging information.
Main Methods:
- Proposed Clinical Stage Prompt induced Multimodal Prognosis (CiMP) framework.
- Utilized advanced Large Language Models (LLMs) to generate clinical staging prompts from structured records.
- Introduced a Group Multi-Head Self-Attention module for genomic data analysis.
- Integrated WSIs and genomic data for multi-modal prognosis.
Main Results:
- Achieved state-of-the-art performance on five TCGA datasets.
- Demonstrated superiority over previous multi-modal prognostic models.
- Showcased improved clinical interpretability and potential for medical applications.
Conclusions:
- CiMP effectively integrates histology images and genomic data for enhanced cancer survival prediction.
- The framework successfully incorporates clinical knowledge through staging prompts, overcoming limitations of prior methods.
- The proposed approach holds significant promise for advancing personalized cancer medicine and clinical decision-making.
Related Concept Videos
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Acute Pancreatitis II: Clinical Manifestations and Management
180
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
180
Chronic Pancreatitis II: Collaborative Care
130
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
130

